Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Apr;31(4):485–491. doi: 10.1128/aac.31.4.485

Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

J L Ho, M Barza
PMCID: PMC174764  PMID: 3300527

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M. Imipenem: first of a new class of beta-lactam antibiotics. Ann Intern Med. 1985 Oct;103(4):552–560. doi: 10.7326/0003-4819-103-4-552. [DOI] [PubMed] [Google Scholar]
  2. Berne T. V., Yellin A. W., Appleman M. D., Heseltine P. N. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am J Surg. 1982 Jul;144(1):8–13. doi: 10.1016/0002-9610(82)90594-3. [DOI] [PubMed] [Google Scholar]
  3. Busuttil R. W., Davidson R. K., Fine M., Tompkins R. K. Effect of prophylactic antibiotics in acute nonperforated appendicitis: a prospective, randomized, double-blind clinical study. Ann Surg. 1981 Oct;194(4):502–509. doi: 10.1097/00000658-198110000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collier J., Colhoun E. M., Hill P. L. A multicentre comparison of clindamycin and metronidazole in the treatment of anaerobic infections. Scand J Infect Dis Suppl. 1981;26:96–100. [PubMed] [Google Scholar]
  5. David I. B., Buck J. R., Filler R. M. Rational use of antibiotics for perforated appendicitis in childhood. J Pediatr Surg. 1982 Oct;17(5):494–500. doi: 10.1016/s0022-3468(82)80096-1. [DOI] [PubMed] [Google Scholar]
  6. Drusano G. L., Warren J. W., Saah A. J., Caplan E. S., Tenney J. H., Hansen S., Granados J., Standiford H. C., Miller E. H., Jr A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet. 1982 May;154(5):715–720. [PubMed] [Google Scholar]
  7. Finegold S. M., Bartlett J. G., Chow A. W., Flora D. J., Gorbach S. L., Harder E. J., Tally F. P. Management of anaerobic infections. Ann Intern Med. 1975 Sep;83(3):375–389. doi: 10.7326/0003-4819-83-3-375. [DOI] [PubMed] [Google Scholar]
  8. Foster T. J. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev. 1983 Sep;47(3):361–409. doi: 10.1128/mr.47.3.361-409.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gutmann L., Williamson R. A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance. J Infect Dis. 1983 Aug;148(2):316–321. doi: 10.1093/infdis/148.2.316. [DOI] [PubMed] [Google Scholar]
  10. Harding G. K., Buckwold F. J., Ronald A. R., Marrie T. J., Brunton S., Koss J. C., Gurwith M. J., Albritton W. L. Prospective, randomized comparative study of clindamycin, chloramphenicol, and ticarcillin, each in combination with gentamicin, in therapy for intraabdominal and female genital tract sepsis. J Infect Dis. 1980 Sep;142(3):384–393. doi: 10.1093/infdis/142.3.384. [DOI] [PubMed] [Google Scholar]
  11. Henning C., Medén-Britth G., Frölander F., Karlsson J., Dornbusch K. Comparative study of netilmicin/tinidazole versus netilmicin/clindamycin in the treatment of severe abdominal infections. Scand J Infect Dis. 1984;16(3):297–303. doi: 10.3109/00365548409070404. [DOI] [PubMed] [Google Scholar]
  12. Heseltine P. N., Yellin A. E., Appleman M. D., Gill M. A., Chenella F. C., Kern J. W., Berne T. V. Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis. 1983 Aug;148(2):322–329. doi: 10.1093/infdis/148.2.322. [DOI] [PubMed] [Google Scholar]
  13. Kahlmeter G., Dahlager J. I. Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother. 1984 Jan;13 (Suppl A):9–22. doi: 10.1093/jac/13.suppl_a.9. [DOI] [PubMed] [Google Scholar]
  14. King D. R., Browne A. F., Birken G. A., Hilty M. D., Kerzner B., Boles E. T., Jr Antibiotic management of complicated appendicitis. J Pediatr Surg. 1983 Dec;18(6):945–950. doi: 10.1016/s0022-3468(83)80051-7. [DOI] [PubMed] [Google Scholar]
  15. Lau W. Y., Fan S. T., Chu K. W., Suen H. C., Yiu T. F., Wong K. K. Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrob Agents Chemother. 1985 Nov;28(5):639–642. doi: 10.1128/aac.28.5.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lennard E. S., Minshew B. H., Dellinger E. P., Wertz M. J., Heimbach D. M., Counts G. W., Schoenknecht F. D., Coyle M. B. Stratified outcome comparison of clindamycin-gentamicin vs chloramphenicol-gentamicin for treatment of intra-abdominal sepsis. Arch Surg. 1985 Aug;120(8):889–898. doi: 10.1001/archsurg.1985.01390320013002. [DOI] [PubMed] [Google Scholar]
  17. Lorber B., Swenson R. M. The bacteriology of intra-abdominal infections. Surg Clin North Am. 1975 Dec;55(6):1349–1354. doi: 10.1016/s0039-6109(16)40792-9. [DOI] [PubMed] [Google Scholar]
  18. Louie T. J., Onderdonk A. B., Gorbach S. L., Bartlett J. G. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin. J Infect Dis. 1977 Mar;135 (Suppl):S18–S22. doi: 10.1093/infdis/135.supplement.s18. [DOI] [PubMed] [Google Scholar]
  19. MacGregor R. R., Gentry L. O. Imipenem/cilastatin in the treatment of osteomyelitis. Am J Med. 1985 Jun 7;78(6A):100–103. doi: 10.1016/0002-9343(85)90109-3. [DOI] [PubMed] [Google Scholar]
  20. Marier R. L., Marinaccio A. T., Sanders C. V., Aldridge K. E., Mitchell J. W. Susceptibility patterns of bacteria following therapy with piperacillin. J Antimicrob Chemother. 1982 Feb;9 (Suppl B):85–91. doi: 10.1093/jac/9.suppl_b.85. [DOI] [PubMed] [Google Scholar]
  21. McLaughlin F. J., Matthews W. J., Jr, Strieder D. J., Sullivan B., Goldmann D. A. Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis. J Antimicrob Chemother. 1983 May;11 (Suppl B):195–203. doi: 10.1093/jac/11.suppl_b.195. [DOI] [PubMed] [Google Scholar]
  22. Najem A. Z., Kaminski Z. C., Spillert C. R., Lazaro E. J. Comparative study of parenteral piperacillin and cefoxitin in the treatment of surgical infections of the abdomen. Surg Gynecol Obstet. 1983 Nov;157(5):423–425. [PubMed] [Google Scholar]
  23. Nichols R. L., Smith J. W., Klein D. B., Trunkey D. D., Cooper R. H., Adinolfi M. F., Mills J. Risk of infection after penetrating abdominal trauma. N Engl J Med. 1984 Oct 25;311(17):1065–1070. doi: 10.1056/NEJM198410253111701. [DOI] [PubMed] [Google Scholar]
  24. O'Donnell V., Mandal A. K., Lou S. M., Thadepalli H. Evaluation of carbenicillin and a comparison of clindamycin and gentamicin combined therapy in penetrating abdominal trauma. Surg Gynecol Obstet. 1978 Oct;147(4):525–528. [PubMed] [Google Scholar]
  25. Onderdonk A. B., Bartlett J. G., Louie T., Sullivan-Seigler N., Gorbach S. L. Microbial synergy in experimental intra-abdominal abscess. Infect Immun. 1976 Jan;13(1):22–26. doi: 10.1128/iai.13.1.22-26.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Onderdonk A. B., Weinstein W. M., Sullivan N. M., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals. Infect Immun. 1974 Dec;10(6):1256–1259. doi: 10.1128/iai.10.6.1256-1259.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Saah A. J., Drusano G. L., Warren J. W., Tenney J. H., Caplan E. S. Cefoxitin-resistant facultative or aerobic gram-negative bacilli in infections associated with the gastrointestinal tract. Ann Intern Med. 1981 Apr;94(4 Pt 1):487–488. doi: 10.7326/0003-4819-94-4-487. [DOI] [PubMed] [Google Scholar]
  28. Saario I., Arvilommi H., Silvola H. Comparison of cefuroxime and gentamicin in combination with metronidazole in the treatment of peritonitis due to perforation of the appendix. Acta Chir Scand. 1983;149(4):423–426. [PubMed] [Google Scholar]
  29. Salata R. A., Gebhart R. L., Palmer D. L., Wade B. H., Scheld W. M., Groschel D. H., Wenzel R. P., Mandell G. L., Duma R. J. Pneumonia treated with imipenem/cilastatin. Am J Med. 1985 Jun 7;78(6A):104–109. doi: 10.1016/0002-9343(85)90110-x. [DOI] [PubMed] [Google Scholar]
  30. Sanders C. C., Sanders W. E., Jr Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. Rev Infect Dis. 1983 Jul-Aug;5(4):639–648. doi: 10.1093/clinids/5.4.639. [DOI] [PubMed] [Google Scholar]
  31. Schentag J. J., Wels P. B., Reitberg D. P., Walczak P., Van Tyle J. H., Lascola R. J. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis. Ann Surg. 1983 Jul;198(1):35–41. doi: 10.1097/00000658-198307000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scully B. E., Neu H. C. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria. Arch Intern Med. 1984 Jan;144(1):57–62. doi: 10.1001/archinte.144.1.57. [DOI] [PubMed] [Google Scholar]
  33. Simon G. L., Snydman D. R., Tally F. P., Gorbach S. L. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. Antimicrob Agents Chemother. 1980 Jul;18(1):167–170. doi: 10.1128/aac.18.1.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Smith J. A., Skidmore A. G., Forward A. D., Clarke A. M., Sutherland E. Prospective, randomized, double-blind comparison of metronidazole and tobramycin with clindamycin and tobramycin in the treatment of intra-abdominal sepsis. Ann Surg. 1980 Aug;192(2):213–220. doi: 10.1097/00000658-198008000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Solomkin J. S., Fant W. K., Rivera J. O., Alexander J. W. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections. Am J Med. 1985 Jun 7;78(6A):85–91. doi: 10.1016/0002-9343(85)90106-8. [DOI] [PubMed] [Google Scholar]
  36. Tally F. P., Cuchural G. J., Jr, Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother. 1985 Nov;28(5):675–677. doi: 10.1128/aac.28.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tally F. P., Kellum J. M., Ho J. L., O'Donnell T. F., Barza M., Gorbach S. L. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections. Antimicrob Agents Chemother. 1986 Feb;29(2):244–249. doi: 10.1128/aac.29.2.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tally F. P., McGowan K., Kellum J. M., Gorbach S. L., O'Donnell T. F. A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis. Ann Surg. 1981 Mar;193(3):318–323. doi: 10.1097/00000658-198103000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Thadepalli H., Gorbach S. L., Broido P. W., Norsen J., Nyhus L. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet. 1973 Aug;137(2):270–276. [PubMed] [Google Scholar]
  40. Van der Auwera P., Collier J., Goris R. J., Saario I., Willis A. T. A comparison of metronidazole and clindamycin for the treatment of intra-abdominal anaerobic infection: a multicentre trial. J Antimicrob Chemother. 1982 Jul;10(1):57–66. doi: 10.1093/jac/10.1.57. [DOI] [PubMed] [Google Scholar]
  41. Wald E. R., Standiford H. C., Tatem B. A., Calia F. M., Hornick R. B. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1975 Mar;7(3):336–340. doi: 10.1128/aac.7.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Young M. J., Bresnitz E. A., Strom B. L. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med. 1983 Aug;99(2):248–251. doi: 10.7326/0003-4819-99-2-248. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES